New Heritage Realizes Investment in Rhythmlink
New Heritage exits its investment in Rhythmlink, the market-leading designer and manufacturer of single-use brain health and neurodiagnostic electrodes. New Heritage first invested in Rhythmlink in February 2019 and sold the Company to Graham Partners after successfully executing a strategic and operational growth plan that sets up Rhythmlink for continued expansion. GroveStreet first become a New Heritage LP in 2014. Read more about the deal here: https://www.newheritagecapital.com/new-heritage-capital-exits-investment-in-portfolio-company-rhythmlink/